Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

TNF blockers linked to cancer risk in children & teens

August 5, 2009

TNF blockers linked to cancer risk in children & teens | benkazie.wordpress.com

The Food and Drug Administration said Tuesday there’s an increased risk of lymphoma and other cancers associated with the use of drugs like Remicade [infliximab] and Humira [adalimumab] in children and adolescents.  The FDA is requiring stronger warnings regarding the risk for cancer associated with tumor necrosis factor (TNF) blockers. 

Mortality risk low 15 years after radical prostatectomy

July 29, 2009

Mortality risk low 15 years after radical prostatectomy | benkazie.wordpress.com

http://benkazie.wordpress.com/2009/07/29/mortality-risk-low-15-years-after-radical-prostatectomy/ The fact remains that prostate cancer kills almost 30,000 men each year. It is also true that we are getting better at making more educated guesses regarding which men are most at risk to progress with prostate cancer.  Finally, it has long been true that radical prostatectomy has been felt to be superior to all other forms of treatment in terms of achieving a long term cure of prostate cancer .

Tanning beds cause cancer

July 29, 2009

Tanning beds cause cancer | benkazie.wordpress.com

http://benkazie.wordpress.com/2009/07/29/quick-post-tanning-beds-may-cause-cancer/ Tanning beds pose as big a risk as tobacco and asbestos.

The Genie is Out of the Bottle

January 31, 2008

Nycomed and Wyeth announce launch of an own generic version of PROTONIX(R) | www.pipelinereview.com

- the fact is that the genie is out of the bottle - Protonix has long been viewed negatively by health plans due to cost - insurers are "forcing" subscribers to move to the generic version  - thist further weakens patent protections .

Page : 11 to 4 of 4

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG